Related Experiment Video
Updated: Feb 4, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer
Mohammed Sedki1, Islam A Khalil1,2, Ibrahim M El-Sherbiny1
1a Nanomedicine Lab , Center of Materials Science (CMS), Zewail City of Science and Technology , 6th of October , Giza , Egypt.
Abstract:
Prostate cancer is the most common non-skin cancer among men. Though statins are mainly used as antihyperlipidemic drugs, many studies have reported their proapoptotic and antimetastatic activities on prostate cancer. However, the poor solubility and insufficient delivery of statins in tumor site limit their anticancer activity. The present study introduces an efficient hybrid drug delivery system for the treatment of prostate cancer. The system involves the chemical conjugation of Simvastatin (SMV), a statin compound, to acid-terminated poly(D, L-lactic-co-glycolic acid), PLGA chains followed by its conversion into nanoparticles (NPs), with in situ physical incorporation of more SMV and superparamagnetic iron oxide nanoparticles (SPIONS) into the PLGA NPs. The PLGA-based hybrid nanocarrier system has been designed in such a way to evade the low bioavailability of SMV, confer sustained release of both encapsulated and chemically conjugated SMV, as well as enhancing the anti-cancer effect of the formula via the magnetic targeting with the aid of the encapsulated SPIONS. Magnetism, morphological and physicochemical characterizations, as well as in-vitro release studies were performed. Besides, cytotoxicity on human prostate cancer cell line (PC-3) was evaluated using MTT assay, cell cycle arrest analysis, annexin V/propidium iodide apoptosis assay and ELISA immunoassay for apoptotic enzyme. Optimum PLGA-based hybrid nanocarrier significantly improved the SMV anticancer activity against human prostate cancer cell line through both apoptosis mechanism and retardation of G2-M phase of cell cycle. Also, the up-regulation of the Caspase 3 was aligned with cytotoxicity study's findings.
Insights
This study developed a novel hybrid nanocarrier for prostate cancer treatment. The system enhances Simvastatin delivery and anticancer effects, improving apoptosis and cell cycle arrest in cancer cells.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Prostate cancer is a leading non-skin cancer in men.
- Statins show promise against prostate cancer but suffer from poor solubility and tumor site delivery.
- Developing effective drug delivery systems is crucial for enhancing statin efficacy.
Purpose of the Study:
- To create an efficient hybrid drug delivery system for prostate cancer treatment.
- To overcome the limitations of Simvastatin (SMV) bioavailability and tumor targeting.
- To enhance the anticancer activity of SMV using a novel nanocarrier.
Main Methods:
- Chemical conjugation of Simvastatin (SMV) to poly(D, L-lactic-co-glycolic acid) (PLGA) chains.
- Formation of nanoparticles (NPs) with incorporated SMV and superparamagnetic iron oxide nanoparticles (SPIONS).
- In vitro evaluation including physicochemical characterization, drug release studies, and cytotoxicity assays (MTT, cell cycle, apoptosis) on PC-3 cells.
Main Results:
- The PLGA-based hybrid nanocarrier system demonstrated improved SMV bioavailability and sustained release.
- The nanocarrier significantly enhanced anticancer activity against human prostate cancer cells (PC-3).
- Observed effects included apoptosis induction and G2-M phase cell cycle arrest, with up-regulation of Caspase 3.
Conclusions:
- The developed PLGA-based hybrid nanocarrier is an effective system for prostate cancer therapy.
- The system successfully enhances Simvastatin's anticancer efficacy through apoptosis and cell cycle modulation.
- Magnetic targeting via SPIONS offers a promising strategy for improved drug delivery in prostate cancer treatment.
Related Concept Videos
Hybrid Zones
Hybridization of Atomic Orbitals I
Hybridization of Atomic Orbitals II
In-situ Hybridization
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
IR Absorption Frequency: Hybridization
Among the sp, sp2, and sp3 hybridized orbitals, sp orbitals have the maximum s character (50%). Consequently, the electrons are held more closely to the nucleus, resulting in stronger and shorter C–H bonds that...

